Published in J Neurooncol on April 08, 2010
A nomogram for individualized estimation of survival among patients with brain metastasis. Neuro Oncol (2012) 1.32
Optimizing therapy for radioactive iodine-refractory differentiated thyroid cancer: current state of the art and future directions. Minerva Endocrinol (2012) 1.00
Brain metastasis from papillary thyroid carcinomas. Mol Clin Oncol (2013) 0.78
Clinical outcomes of a cohort of patients with central nervous system metastases from thyroid cancer. Endocr Connect (2016) 0.75
Metastatic cerebellar tumor of papillary thyroid carcinoma mimicking cerebellar hemangioblastoma. Springerplus (2016) 0.75
The Largest Known Survival Analysis of Patients with Brain Metastasis from Thyroid Cancer Based on Prognostic Groups. PLoS One (2016) 0.75
Hürthle cell carcinoma: current perspectives. Onco Targets Ther (2016) 0.75
Radiotherapy and short-term androgen deprivation for localized prostate cancer. N Engl J Med (2011) 7.46
Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys (2009) 6.11
Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402. J Clin Oncol (2006) 4.88
Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol (2011) 4.12
Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402. J Clin Oncol (2012) 3.96
Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases. J Clin Oncol (2003) 2.69
Benefit from procarbazine, lomustine, and vincristine in oligodendroglial tumors is associated with mutation of IDH. J Clin Oncol (2014) 2.42
A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. Int J Radiat Oncol Biol Phys (2002) 2.09
A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment. Breast Cancer Res (2003) 2.09
RTOG sarcoma radiation oncologists reach consensus on gross tumor volume and clinical target volume on computed tomographic images for preoperative radiotherapy of primary soft tissue sarcoma of extremity in Radiation Therapy Oncology Group studies. Int J Radiat Oncol Biol Phys (2011) 2.06
A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation Therapy Oncology Group 0320. Int J Radiat Oncol Biol Phys (2013) 2.02
An assessment of PTV margin definitions for patients undergoing conformal 3D external beam radiation therapy for prostate cancer based on an analysis of 10,327 pretreatment daily ultrasound localizations. Int J Radiat Oncol Biol Phys (2007) 2.00
Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro Oncol (2013) 1.88
Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases. Int J Radiat Oncol Biol Phys (2011) 1.74
Intensity-modulated radiotherapy for craniospinal irradiation: target volume considerations, dose constraints, and competing risks. Int J Radiat Oncol Biol Phys (2007) 1.64
The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys (2005) 1.59
Standard and nonstandard craniospinal radiotherapy using helical TomoTherapy. Int J Radiat Oncol Biol Phys (2010) 1.55
Variations in PSA doubling time in patients with prostate cancer on "watchful waiting": value of short-term PSADT determinations. Urology (2004) 1.47
Detrimental effects of tumor progression on cognitive function of patients with high-grade glioma. J Clin Oncol (2006) 1.39
A nomogram for individualized estimation of survival among patients with brain metastasis. Neuro Oncol (2012) 1.32
Rethinking the use of radiation and chemotherapy after radical hysterectomy: a clinical-pathologic analysis of a Gynecologic Oncology Group/Southwest Oncology Group/Radiation Therapy Oncology Group trial. Gynecol Oncol (2005) 1.31
The use of hypofractionated intensity-modulated irradiation in the treatment of glioblastoma multiforme: preliminary results of a prospective trial. Int J Radiat Oncol Biol Phys (2004) 1.24
Hematologic toxicity in RTOG 0418: a phase 2 study of postoperative IMRT for gynecologic cancer. Int J Radiat Oncol Biol Phys (2013) 1.19
Short delay in initiation of radiotherapy may not affect outcome of patients with glioblastoma: a secondary analysis from the radiation therapy oncology group database. J Clin Oncol (2008) 1.17
What is your patient's GPA and why does it matter? Managing brain metastases and the cost of hope. Int J Radiat Oncol Biol Phys (2010) 1.16
A phase II trial of accelerated radiotherapy using weekly stereotactic conformal boost for supratentorial glioblastoma multiforme: RTOG 0023. Int J Radiat Oncol Biol Phys (2006) 1.13
Failure pattern following complete resection plus radiotherapy and temozolomide is at the resection margin in patients with glioblastoma. J Neurooncol (2012) 1.12
Age as an independent prognostic factor in patients with glioblastoma: a Radiation Therapy Oncology Group and American College of Surgeons National Cancer Data Base comparison. J Neurooncol (2011) 1.09
Accelerated hypofractionated intensity-modulated radiotherapy with concurrent and adjuvant temozolomide for patients with glioblastoma multiforme: a safety and efficacy analysis. Int J Radiat Oncol Biol Phys (2008) 1.08
Utility of PSA doubling time in follow-up of untreated patients with localized prostate cancer. Urology (2002) 1.07
A phase II study of intensity modulated radiation therapy to the pelvis for postoperative patients with endometrial carcinoma: radiation therapy oncology group trial 0418. Int J Radiat Oncol Biol Phys (2012) 1.06
The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma. Int J Radiat Oncol Biol Phys (2005) 1.05
Silver leaf nylon dressing to prevent radiation dermatitis in patients undergoing chemotherapy and external beam radiotherapy to the perineum. Int J Radiat Oncol Biol Phys (2004) 1.03
Erythropoietin induces cancer cell resistance to ionizing radiation and to cisplatin. Mol Cancer Ther (2004) 1.02
The prostate cancer risk stratification (ProCaRS) project: recursive partitioning risk stratification analysis. Radiother Oncol (2013) 1.01
Role of repeated biopsy of the prostate in predicting disease progression in patients with prostate cancer on active surveillance. Cancer (2008) 1.01
Conformal preoperative endorectal brachytherapy treatment for locally advanced rectal cancer: early results of a phase I/II study. Dis Colon Rectum (2002) 1.00
Radiobiological basis of SBRT and SRS. Int J Clin Oncol (2014) 0.99
Pre-treatment risk stratification of prostate cancer patients: A critical review. Can Urol Assoc J (2012) 0.99
Impact of FDG-PET/CT on radiotherapy volume delineation in non-small-cell lung cancer and correlation of imaging stage with pathologic findings. Int J Radiat Oncol Biol Phys (2007) 0.98
Safety and feasibility of motexafin gadolinium administration with whole brain radiation therapy and stereotactic radiosurgery boost in the treatment of ≤ 6 brain metastases: a multi-institutional phase II trial. J Neurooncol (2011) 0.98
Bladder conservation treatment in the elderly population: results and prognostic factors of muscle-invasive bladder cancer. Am J Clin Oncol (2009) 0.97
Preponderance of sonic hedgehog pathway activation characterizes adult medulloblastoma. Acta Neuropathol (2010) 0.97
Variation in the gross tumor volume and clinical target volume for preoperative radiotherapy of primary large high-grade soft tissue sarcoma of the extremity among RTOG sarcoma radiation oncologists. Int J Radiat Oncol Biol Phys (2011) 0.96
Characteristics and outcomes of medulloblastoma in adults. Pediatr Blood Cancer (2008) 0.94
The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancer. J Neurooncol (2013) 0.94
Killing two birds with one stone: a dosimetric study of dual target radiosurgery using a single isocenter. Technol Cancer Res Treat (2006) 0.92
Cognition and quality of life after chemotherapy plus radiotherapy (RT) vs. RT for pure and mixed anaplastic oligodendrogliomas: radiation therapy oncology group trial 9402. Int J Radiat Oncol Biol Phys (2009) 0.91
Predictive parameters of CyberKnife fiducial-less (XSight Lung) applicability for treatment of early non-small cell lung cancer: a single-center experience. Int J Radiat Oncol Biol Phys (2013) 0.90
Hypofractionated radiation therapy (66 Gy in 22 fractions at 3 Gy per fraction) for favorable-risk prostate cancer: long-term outcomes. Int J Radiat Oncol Biol Phys (2013) 0.89
Prophylactic cranial irradiation in advanced breast cancer: a case for caution. Int J Radiat Oncol Biol Phys (2008) 0.89
Agreement among RTOG sarcoma radiation oncologists in contouring suspicious peritumoral edema for preoperative radiation therapy of soft tissue sarcoma of the extremity. Int J Radiat Oncol Biol Phys (2013) 0.89
No immediate treatment after biochemical failure in patients with prostate cancer treated by external beam radiotherapy. Urology (2006) 0.89
Absence of toxicity with hypofractionated 3-dimensional radiation therapy for inoperable, early stage non-small cell lung cancer. Radiat Oncol (2006) 0.88
Rotational total skin electron irradiation with a linear accelerator. J Appl Clin Med Phys (2008) 0.88
Ultrasound-based image guided radiotherapy for prostate cancer: comparison of cross-modality and intramodality methods for daily localization during external beam radiotherapy. Int J Radiat Oncol Biol Phys (2006) 0.88
Long-term results of high-dose-rate brachytherapy in the primary treatment of medically inoperable stage I-II endometrial carcinoma. Int J Radiat Oncol Biol Phys (2005) 0.87
Whole-brain radiotherapy and tumor bed radiosurgery following resection of solitary brain metastases. J Neurooncol (2009) 0.87
Waldenstrom's macroglobulinemia presenting with spinal cord compression: a case report. Am J Hematol (2006) 0.87
Cardiac embolization of an implanted fiducial marker for hepatic stereotactic body radiotherapy: a case report. J Med Case Rep (2009) 0.86
Treating intermediate-risk prostate cancer with hypofractionated external beam radiotherapy alone. Radiother Oncol (2011) 0.86
Local correlation between monte-carlo dose and radiation-induced fibrosis in lung cancer patients. Int J Radiat Oncol Biol Phys (2008) 0.86
Protracted hypofractionated radiotherapy for Graves' ophthalmopathy: a pilot study of clinical and radiologic response. Int J Radiat Oncol Biol Phys (2011) 0.86
Development and impact evaluation of an e-learning radiation oncology module. Int J Radiat Oncol Biol Phys (2011) 0.85
Hypofractionated radiotherapy for favorable risk prostate cancer. Int J Radiat Oncol Biol Phys (2010) 0.85
Phase II multicenter study of induction chemotherapy followed by concurrent efaproxiral (RSR13) and thoracic radiotherapy for patients with locally advanced non-small-cell lung cancer. J Clin Oncol (2005) 0.85
Prostate gland edema after single-fraction high-dose rate brachytherapy before external beam radiation therapy. Brachytherapy (2010) 0.84
Stage III endometrial cancer: preoperative predictability, prognostic factors, and treatment outcome. Am J Obstet Gynecol (2007) 0.83
Adaptation of wives to prostate cancer following diagnosis and 3 months after treatment: a test of family adaptation theory. Int J Nurs Stud (2006) 0.83
Long-term results of para-aortic irradiation for patients with stage I seminoma of the testis. Int J Radiat Oncol Biol Phys (2005) 0.83
Implanting metal fiducials to guide stereotactic liver radiation: McGill experience and review of current devices, techniques and complications. Technol Cancer Res Treat (2013) 0.83
Analysis of prognostic factors and patterns of recurrence in patients with pathologic stage III endometrial cancer. Int J Radiat Oncol Biol Phys (2007) 0.82
Low-grade oligodendroglioma: an indolent but incurable disease? Clinical article. J Neurosurg (2009) 0.82
Metabolic activity measured on PET/CT correlates with clinical outcomes in patients with limb and girdle sarcomas. J Surg Oncol (2013) 0.81
PET/CT for radiotherapy treatment planning in patients with soft tissue sarcomas. Int J Radiat Oncol Biol Phys (2009) 0.81
Tumor bed radiosurgery following resection of brain metastases: a review. Technol Cancer Res Treat (2010) 0.81
Preoperative intensity modulated radiation therapy for retroperitoneal sarcoma. Technol Cancer Res Treat (2013) 0.81
Local recurrence after initial multidisciplinary management of soft tissue sarcoma: is there a way out? Clin Orthop Relat Res (2010) 0.81
Single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiation therapy in the treatment of intermediate-risk prostate cancer - long term results. Int J Radiat Oncol Biol Phys (2011) 0.81
Volumetric measurement of vestibular schwannoma tumour growth following partial resection: predictors for recurrence. J Neurol Surg B Skull Base (2012) 0.81
The prostate cancer risk stratification project: database construction and risk stratification outcome analysis. J Natl Compr Canc Netw (2014) 0.80
Is there a detrimental effect of waiting for radiotherapy for patients with localized prostate cancer? Am J Clin Oncol (2006) 0.79
Current standards in the management of cerebral metastases. Int J Surg Oncol (2011) 0.79
Acute and late toxicities of radiotherapy for patients with discoid lupus erythematosus: a retrospective case-control study. Radiat Oncol (2012) 0.79
Psychosocial adjustment of men during the first year of prostate cancer. Cancer Nurs (2012) 0.79
Stereotactic radiotherapy of the liver: a bridge to transplantation stereotactic radiotherapy of the liver: a bridge to transplantation. Technol Cancer Res Treat (2009) 0.78
Phase II multicenter trial with carboplatin and gemcitabine induction chemotherapy followed by radiotherapy concomitantly with low-dose paclitaxel and gemcitabine for stage IIIA and IIIB non-small cell lung cancer. J Thorac Oncol (2007) 0.78
Cone beam CT-based three-dimensional planning in high-dose-rate brachytherapy for cervical cancer. Int J Radiat Oncol Biol Phys (2009) 0.77
Reporting late rectal toxicity in prostate cancer patients treated with curative radiation treatment. Int J Radiat Oncol Biol Phys (2008) 0.77
Contemporary outcome and management of patients who had an aborted cystectomy due to unresectable bladder cancer. Urol Oncol (2009) 0.77
When temozolomide alone fails: adding procarbazine in salvage therapy of glioma. Can J Neurol Sci (2008) 0.77